Chinese and western drugs for curing bird bacillus coli disease and method of preparing the same

Abstract

The invention relates to a Chinese and western drug for treating avian escherichia coli diseases. The invention is characterized in that the Chinese and western drug comprises the components by weight parts as follows: rhubarb is 10 to 30 parts, radix scutellariae is 5 to 15 parts, coptis roots are 1 to 5 parts, radix isatidis is 1 to 5 parts, and enrofloxacin is 0.5 to 5 parts. The invention has a preparation method as follows: (1) the components are got by weight parts as follows: the rhubarb is 10 to 30 parts, the radix scutellariae is 5 to 15 parts, the radix isatidis is 1 to 5 parts, and the radix isatidis is 1 to 5 parts; (2) purified water which is 2 to 3 times the weight of the total quantity of all components is added, and concentrated solution is obtained after diacolation, evaporation and concentration, wherein, the relative density of the concentrated solution is 1.05 to 1.2; (3) the enrofloxacin which is 0.1 to 1 time the weight of the concentrated solution is added in the concentrated solution, and the purified water which is 2 to 5 the weight of the concentrated solution is added, so that the Chinese and western drug is made. The invention has strengthening efficacy after extraction and separation, effectively treats chicken escherichia infection, and reduces the economic loss of raising households. The Chinese and western drug realizes the reasonable collocation and combination by selecting various active ingredients, the cost is low, the curative effect is good, the cure rate is high, and the safety and the reliability are realized.

Description

technical field [0001] The invention relates to a medicine for treating poultry diseases, in particular to a Chinese and Western medicine for treating poultry Escherichia coli diseases and a preparation method thereof. Background technique [0002] Avian colibacillosis is a common multiple infectious disease caused by pathogenic Escherichia coli, including a variety of disease types, and is complex and diverse. It is one of the most important bacterial diseases that endanger the poultry industry. The mortality rate of sick poultry can reach 8-10%. The body resistance of sick poultry decreases, and it is easy to be infected with other pathogenic microorganisms, such as mycoplasma infection and viral infection, resulting in increased mortality. Generally, the cost of medicines for the treatment of poultry colibacillosis accounts for about 10% of the cost of medicines for the whole poultry farming. At present, the aquaculture industry mostly uses chemically synthesized drugs s...

AI Technical Summary

Problems solved by technology

At present, the aquaculture industry mostly uses chemically synthesized drugs such as antibiotics to treat the disease, but the use of antibiotics will cause the drugs to remain in the poultry, resulting in a decline in the quality of poultry products. In addition, long-term use can also make E. coli resistant to antibiotics, making the antibiotics Decreased antibacterial activity